“…Symptomatic cardiovascular involvement occurs in 27-47% of Churg-Strauss cases, being one of the most serious manifestations. 4 It is characterized by necrotizing vasculitis with granulomatous inflammation and eosinophils infiltration, predominantly affecting small to medium vessels, in association with asthma and eosinophilia. 5 EGPA's clinical phenotypes are usually classified according to ANCA status, as the major eosinophil-driven complications are most frequently found in the ANCA-negative form of EGPA, namely, lung infiltrates, myocardiopathy, and gastrointestinal manifestations.…”